A STUDY ON HUMAN IMMUNODEFICIENCY VIRUS-1 (HIV-1) PROTEASE INHIBITION BY EXTRACTS OF FRESH WATER MUSSEL
Human immunodeficiency virus type-1 (HIV-1) is the cause of acquired immune deficiency syndrome (AIDS). Failure in anti-AIDS treatment is observed due to the emergence of resistant viruses, cross-resistance to drugs and cell toxicity. The objective of this study is “To study the in vitro HIV-1 protease activity of fresh water mussel extract”. Live freshwater mussels (Lamellidens marginalis Li.) were collected from various places of Godavari river, Adilabad district, Andhra Pradesh. Bioactive crude extract from the animal tissue samples was extracted with using protein extraction buffer. Partially purified extract (PPE) prepared by ammonium sulphate precipitation from crude extract. The PPE tested for cytotoxicity on cultured PBMCs and was assayed for HIV-1 protease inhibitory activity. Cytotoxicity became prominent (>50% cell death) on day 4 at extracts concentration of 400 µg/ml and higher. On day 4, >70% inhibition in protease titer was seen with extract at 100 µg/ml.
Ahn JE, Salzman RA, Braunagel SC, Koiwa H, and Zhu-Salzman K. (2004). “Functional roles of specific bruchid protease isoforrns in adaptation to a soybean protease inhibitor”, Insect Mol Biol, Vol.13(6), pp.649- 657.
Bichurina MA, Nikitina LE, Sovetowa MG, Rekhina NI, Besedina TV, Boikov YA, and Noskov FS. (1994). “The virus-inhibiting activity of a preparation obtained from a mussel hydrolysate”, Vopr. Virusol, Vol. 3, pp.134-136.
Borman AM, Paulous S, and Clavel F. (1996). “Resistance of human immunodeficiency type 1 protease inhibitors: Selection of resistance mutations in the presence and absence of the drug”, J Gen Virol, Vol.77, pp.419-426.
Chatterji A, Ansari ZA, Ingole BS, Bichurina MA, Sovetova M, and Boikov YA. (2002). “Indian marine bivalves: Potential source of antiviral drugs”, Curr Science, Vol.81(10), pp. 279-1282.
Cyran R. (2002). “New developments in therapeutic enzyme inhibitors and blockers”, BCC Research, Norwalk, C-202R.
Englard S, and Seifter S. (1990). “Precipitation Techniques”, Methods Enzymol, Academic Press.Inc. pp. 285-300.
Estari M, Venkanna L, and Reddy AS. (2012). “In vitro anti-HIV activity of crude extracts from Tinospora cordifolia”, BMC Infectious Diseases, Vol.12(1), p.10.
Huerta-Reyes M, Basualdo MC, Abe F, Jimenez-Estrada M, Soler C, Reves-Chilpa R. (2004). “HIV-1 inhibitory compounds from Calophyllum brasiliense leaves”, Biol Pharm Bull, Vol.27(9), pp.1471-1475.
Imada C. (2005). “Enzyme inhibitors and other bioactive compounds from marine actinomycetes”, Antonie van Leeuwenhoek, Vol.87(1), pp.59-63.
Johnson S, and Pellecchia M. (2006). “Structure- and fragment based approaches to protease inhibition”, Curl' Top Med Chem, Vol.6, pp.317-329.
Kohl NE, Emini EA, and Schleif WA. (1988). “Active human immunodeficiency virus protease is required for viral infectivity”, Proc. Natl. Acad. Sci. USA, Vol.85(13), pp.4686-4690.
Ma CM, Nakamura N, Miyashiro H, and Hattori M. (1998). “Saponins and C-glycosyl flavones from the seeds of Abrus precatorius”, Chem. Pharm. Bull, Vol.46, pp.982-987.
Magadula JJ, Kapingu MC, Bezabih M, and Abegaz BM. (2008). “Polyisoprenylated benzophenones from Garcinia semseii (Clusiaceae)”, Phytochem Lett, Vol.1, pp.215-218.
Orosalan S. (1989). “Biosynthesis and proteolytic processing of retroviral proteins: an overview”, Current communications in molecular biology- viral protienases as targets for chemotherapy, Cold Spring Harbor laboratory press, New York, pp.87-100.
Schroeder CI, Smythe M L, and Lewis RJ. (2004). “Development of small molecules that mimic the binding of omega-conotoxins at the N-type voltage gated calcium channel”, Mol Divers, Vol.8(2), pp.127-134.
Tantillo C, Ding J, Nanni RG, and Boyer PL. (1994). “Location of Anti-AIDS drug binding sites and resistance mutations in the three dimensional structure of HIV-1 reverse transcriptase implications for mechanism of drug inhibition and resistance”, Journal of Molecular Biology, Vol.243(3), pp.369-387.
- There are currently no refbacks.
Send mail to firstname.lastname@example.org with questions or comments about this web site.
International Journal of Medical and Pharma Research, All rights reserved.